Mark M. Painter

4.3k total citations
13 papers, 281 citations indexed

About

Mark M. Painter is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Mark M. Painter has authored 13 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Immunology. Recurrent topics in Mark M. Painter's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Mark M. Painter is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (4 papers). Mark M. Painter collaborates with scholars based in United States, Germany and United Kingdom. Mark M. Painter's co-authors include Kathleen L. Collins, Valeri H. Terry, E. John Wherry, Jennifer E. Wu, Giorgos C. Karakousis, Divij Mathew, Amy E. Baxter, Sasikanth Manne, Xiaowei Xu and Yinghui Huang and has published in prestigious journals such as Nature Communications, Immunity and Nature Immunology.

In The Last Decade

Mark M. Painter

9 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark M. Painter United States	7	155	98	91	74	62	13	281
David S. Quinn United States	4	124 0.8×	139 1.4×	41 0.5×	68 0.9×	133 2.1×	8	268
Nadia Kettaf Canada	7	262 1.7×	118 1.2×	60 0.7×	29 0.4×	67 1.1×	8	373
Mary-Aude Rochat Switzerland	10	142 0.9×	157 1.6×	83 0.9×	35 0.5×	67 1.1×	11	301
Marie‐Ève Blais United Kingdom	10	237 1.5×	102 1.0×	60 0.7×	24 0.3×	72 1.2×	12	344
Arnaud D. Colantonio United States	9	253 1.6×	100 1.0×	42 0.5×	57 0.8×	45 0.7×	11	360
Yvonne B. Sullivan United States	6	193 1.2×	92 0.9×	37 0.4×	41 0.6×	23 0.4×	11	245
Kirsten M. Knecht United States	8	113 0.7×	85 0.9×	45 0.5×	32 0.4×	122 2.0×	12	246
E. Lake Potter United States	6	122 0.8×	50 0.5×	31 0.3×	80 1.1×	89 1.4×	8	237
Sultan Abdul-Jawad United Kingdom	6	165 1.1×	123 1.3×	46 0.5×	72 1.0×	119 1.9×	12	276
Mahmoud Mohammad Yaseen Jordan	10	177 1.1×	76 0.8×	42 0.5×	64 0.9×	55 0.9×	20	306

Countries citing papers authored by Mark M. Painter

Since Specialization

Citations

This map shows the geographic impact of Mark M. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Painter more than expected).

Fields of papers citing papers by Mark M. Painter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Painter. The network helps show where Mark M. Painter may publish in the future.

Co-authorship network of co-authors of Mark M. Painter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Painter. A scholar is included among the top collaborators of Mark M. Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Painter. Mark M. Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Feng, Yanbo, Patryk Orzechowski, Jingxuan Bao, et al.. (2025). Automated cytometric gating with human-level performance using bivariate segmentation. Nature Communications. 16(1). 1576–1576.

Terry, Valeri H., et al.. (2024). Variation in HIV-1 Tat activity is a key determinant in the establishment of latent infection. JCI Insight. 10(2). 2 indexed citations

Pereira, Filipa, Mark M. Painter, Andrew W. Robertson, et al.. (2024). Structure–Activity Relationships of Natural and Semisynthetic Plecomacrolides Suggest Distinct Pathways for HIV-1 Immune Evasion and Vacuolar ATPase-Dependent Lysosomal Acidification. Journal of Medicinal Chemistry. 67(6). 4483–4495. 1 indexed citations

Johnston, Timothy S., Mark M. Painter, Naomi R. Douek, et al.. (2024). Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants. Immunity. 57(4). 912–925.e4. 33 indexed citations

Terry, Valeri H., et al.. (2022). Hematopoietic Stem and Progenitor Cells (HSPCs). Methods in molecular biology. 2407. 115–154.

Giles, Josephine R., Shin Foong Ngiow, Sasikanth Manne, et al.. (2022). Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics. Nature Immunology. 23(11). 1600–1613. 119 indexed citations

Nicolas, Alexandre, Gérémy Sannier, Mathieu Dubé, et al.. (2022). A Long Interval Between Priming and Boosting SARS-CoV-2 mRNA Vaccine Doses Enhances B Cell Responses With Limited Impact on T Cell Immunity. SSRN Electronic Journal.

Virgilio, Maria, David R. Collins, Brian G. Peterson, et al.. (2020). Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. eLife. 9. 24 indexed citations

Terry, Valeri H., Mark M. Painter, Maria Virgilio, et al.. (2018). Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients. Cell Reports. 25(13). 3759–3773.e9. 33 indexed citations

10.

Painter, Mark M., et al.. (2018). Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression. Journal of Virology. 92(6). 44 indexed citations

11.

Painter, Mark M., et al.. (2017). Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors. Journal of Virology. 91(24). 17 indexed citations

12.

Hippisley–Cox, Julia, Sue Smith, Gillian Smith, et al.. (2006). QFLU: new influenza monitoring in UK primary care to support pandemic influenza planning. Weekly releases (1997–2007). 11(25). E060622.4–E060622.4. 8 indexed citations

13.

Regan, Martyn, et al.. (2002). Surveillance of influenza in the North-West Region of England 2001-02. Eurosurveillance. 7(12). 174–180.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact